This opportunity funds projects developing point-of-care diagnostic tools that accelerate therapeutic decisions through fast and accurate testing. Funded activities should improve sensitivity, selectivity, ease of use, and address challenges like sample preparation, miniaturization, and regulatory compliance. The focus includes diagnostics for infectious and non-communicable diseases, leveraging mobile technologies and meeting WHO REASSURED criteria.
Eligible applicants include legal entities established in EU and associated countries, with specific provisions for US entities and restrictions on entities controlled by China. Proposals must comply with admissibility conditions including blind evaluation and page limits. Financial and operational
